معرفی
Arnaud Fontanet is a Professor and Head of the Research and Expertise Unit in Emerging Disease Epidemiology at the Institut Pasteur in Paris, affiliated with the School of Public Health and the Department of Infectious Diseases Epidemiology. His work is central to understanding and controlling emerging infectious diseases globally.
His research focuses on the transmission and prevention of emerging pathogens such as SARS-CoV-2, mpox, Zika, and viral hepatitis (B, C, and E), as well as HIV. He leads major clinical and epidemiological studies, including cohort investigations and therapeutic trials, often in low-resource settings in Africa and Asia in collaboration with the Pasteur Network. His expertise informs public health strategy, notably through his chairmanship of the WHO Technical Advisory Group for Egypt’s National Strategy against Viral Hepatitis.
His recent publications (2025) in top journals like The Lancet and J Infect Dis cover critical topics including hepatitis B mother-to-child transmission, SARS-CoV-2 seroprevalence, and vaccine communication. He is also an active educator, teaching data analysis and epidemiology in the Pasteur-CNAM Master’s program.
- Benefits and risks associated with the COVID-19 vaccine Vaxzevria
- Covid-19, un an après : persistance des anticorps protecteurs et réduction significative...
Fontanet has led numerous significant grants and projects, such as the ComCor study on SARS-CoV-2, the HEPNILE project in Egypt, and the VAXPOX modeling of mpox. He mentors students and collaborates extensively with colleagues across the Institut Pasteur and its international network. His work integrates epidemiology, biostatistics, and clinical research to address pressing global health challenges.
He is involved in several key research platforms and initiatives at the Institut Pasteur, including those focused on emerging infectious diseases, antimicrobial resistance, and the Healthy Human Global Project (Milieu Intérieur). His leadership extends to methodological support and strategic thinking within the institute, particularly in epidemiology and biostatistics.
